Article Text

Download PDFPDF
Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology About the Conservative Management of Ovarian Malignant Tumors
  1. Philippe Morice,
  2. Dominik Denschlag,
  3. Alex Rodolakis,
  4. Nick Reed,
  5. Achim Schneider,
  6. Vesna Kesic and
  7. Nicoletta Colombo
  1. ESGO Task Force for Fertility Preservation in Gynecological Cancer. Geneva, Switzerland.
  1. Address correspondence and reprint requests to Philippe Morice, Service de Chirurgie Gynécologique, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex, France. E-mail: morice{at}


In young patients with borderline ovarian tumor a conservative treatment approach does not seem to have a significant impact on survival, and the outcome regarding fertility is good in general. It can be considered even if noninvasive peritoneal implants are discovered at the time of the initial surgery.

In contrast, in patients with epithelial ovarian cancer, conservative surgery should be considered only in adequately staged patients, with a stage IA grade 1 (and probably 2) serous, mucinous or an endometrioid tumor, including a careful follow-up. Such an approach could also probably be discussed in stage IC grade 1 disease.

In patients with nonepithelial malignant ovarian tumors, conservative surgery is also feasible, particularly in patients with malignant germ cell tumors because of their high chemosensitivity leading to an excellent prognosis in general.

  • Borderline tumor
  • Conservative treatment
  • Epithelial tumor
  • Fertility
  • Nonepithelial tumor
  • Ovarian cancer
  • Recurrence

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.